SEROQUEL ARTICLES

Click here for articles and information on Zyprexa.

---

WEIGHTY ISSUES IN 2007

By Steven Dubovsky, M.D.

The U.S. epidemic of obesity and diabetes holds special meaning for psychiatrists because their patients seem particularly at risk and because many psychotropic medications have metabolic effects. In October, the Food and Drug Administration mandated changes to the label for olanzapine to warn of its associations with increased levels of glucose, cholesterol, and triglyceride levels. This past year saw several studies clarifying these issues. (pdf format 52.8Kb)

Source: Journal Watch Psychiatry
http://psychiatry.jwatch.org
Published December 28, 2007

---

AGAIN, HIGHER MORTALITY WITH ANTIPSYCHOTICS IN PATIENTS WITH DEMENTIA

By Allen S. Brett, M.D.

Although antipsychotic drugs are prescribed widely to control neuropsychiatric symptoms in patients with dementia, recent studies suggest questionable efficacy and an association with increased mortality. ... this study gives us yet another reason to avoid antipsychotic drugs in demented patients. [more ...]

Published in Journal Watch General Medicine
http://general-medicine.jwatch.org/
October 11, 2007

---

Astrazeneca
http://www.astrazeneca.com/pressrelease/4971.aspx
Study finds Seroquel effective and tolerated.

---

AstraZeneca Submits SNDA For SEROQUEL(R) For Bipolar Depression Treatment
http://www.medicalnewstoday.com/medicalnews.php?newsid=35626
Provides information about Astazeneca submitting SNDA for Seroquel.

---

NAMI [National Association of Mental Illness]
http://www.nami.org/template.cfm?section=About_NAMI
NAMI's Fact Sheet on Seroquel (quetiapine).

---

New Seroquel Data Supports Benefits in Bipolar Disorder
http://www.medicalnewstoday.com/medicalnews.php?newsid=25058
Article provides informatin on data presented to the American Psychiatry Association about the effectiveness of Seroquel.

Top of Page